Sailaja Gangadhara

8PUBLICATIONS
72CO-AUTHORS
Innate immunityAgricultural molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 22, 2022
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques.

Anusmita Sahoo, Andrew T Jones, Narayanaiah Cheedarla

|Mar 31, 2022
A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection.

Nanda Kishore Routhu, Sailaja Gangadhara, Lilin Lai

|Feb 08, 2021
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection.

Tysheena P Charles, Samantha L Burton, Prabhu S Arunachalam

|Jan 14, 2021
Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses.

Vineet Joag, Sathi Wijeyesinghe, J Michael Stolley

|May 13, 2020
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers.

Prabhu S Arunachalam, Tysheena P Charles, Vineet Joag

|Nov 22, 2019
Strong TH1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacy.

Venkateswarlu Chamcha, Pradeep B J Reddy, Sunil Kannanganat

Pageof 2

Frequent Collaborators

8 joint publications

Rama Rao Amara

3 joint publications

Cynthia A Derdeyn

3 joint publications

Eric Hunter

2 joint publications

Vijayakumar Velu